by Strados Labs | Mar 25, 2025 | Press Releases
The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
by Strados Labs | Mar 11, 2025 | Blog - Clinical Trial Focus
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects’ cough. As drug developers consider including cough frequency as an endpoint in their studies,...
by Strados Labs | Feb 20, 2025 | Press Releases
The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
by Strados Labs | Nov 7, 2024 | Press Releases
On November 22nd at 12pm EST, Strados Labs participated in an exciting episode on the DTRA-TGIF podcast, hosted by Craig Lipset, Jane Myles, and Dr. Amir Kalali. This episode, titled “Increasing Adoption of Wearables in Clinical Trials,” featured guests Nick...
by Strados Labs | Oct 31, 2024 | Press Releases
Strados Labs, a medical technology company, is excited to announce a new partnership with Trialogics, a clinical trial software and logistics provider. This collaboration will leverage Trialogics’ comprehensive logistical expertise to streamline the distribution and...
